BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 7:36:00 PM | Browse: 1433 | Download: 1173
 |
Received |
|
2013-12-01 09:12 |
 |
Peer-Review Started |
|
2013-12-02 09:54 |
 |
To Make the First Decision |
|
2014-03-12 16:56 |
 |
Return for Revision |
|
2014-03-20 20:13 |
 |
Revised |
|
2014-03-31 01:52 |
 |
Second Decision |
|
2014-07-18 13:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-07-18 13:55 |
 |
Articles in Press |
|
2014-07-18 13:55 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-05 18:39 |
 |
Publish the Manuscript Online |
|
2014-08-17 13:16 |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Review |
Article Title |
Diabetes treatment in patients with renal disease: Is the landscape clear enough?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ioannis Ioannidis |
Funding Agency and Grant Number |
|
Corresponding Author |
Ioannis Ioannidis, MD, PhD, Director of Diabetes Outpatient Clinic, 2nd Department of Internal Medicine, Konstantopoulio Hospital, Nea Ionia, Agias Olgas 3-5, 14233 Athens, Greece. kefion@otenet.gr |
Key Words |
Chronic kidney disease; Diabetes; Antidiabetic drugs; Metformin; Dipeptidyl peptidase 4 inhibitors; Therapeutic algorithm |
Core Tip |
Chronic kidney disease (CKD) is very often among diabetic persons. In every day clinical practice doctors worldwide have to deal with these patients and help them to achieve their metabolic goals. Despite this, many studies of antidiabetic drugs have excluded people with CKD. So, we lack solid evidence on the effectiveness and safety of these drugs. In this review I propose therapeutic algorithms for diabetic patients in different stages of CKD and clarify some questions about the use of popular antidiabetic drugs as metformin and sulfonylureas. |
Publish Date |
2014-08-17 13:16 |
Citation |
Ioannidis I. Diabetes treatment in patients with renal disease: Is the landscape clear enough? World J Diabetes 2014; 5(5): 651-658 |
URL |
http://www.wjgnet.com/1948-9358/full/v5/i5/651.htm |
DOI |
http://dx.doi.org/10.4239/wjd.v5.i5.651 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345